
Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030
Description
Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030
The global carrier screening market size is expected t-reach USD 3.64 billion by 2030, according t-a new study by Polaris Market Research. The report “Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 – 2030” gives a detailed insight int-current market dynamics and provides analysis on future market growth.
The well-established healthcare infrastructure and the rise in innovative product introductions are driving the expansion of the industry. Many countries concentrate their efforts on developing enhanced medical infrastructure that includes enhanced treatment techniques.
Furthermore, developed-country nations have modern healthcare infrastructure integrated with various transmission methods, pushing the rise and need for these techniques throughout such countries. Many people wish t-discover if their genetic or inherited disorders might be transmitted t-their offerings. As a result, these factors are expected t-open up promising growth opportunities for companies in the overall industry during the forecasted period.
Additionally, the increasing prevalence of fetal chromosomal abnormalities boosts industry growth. According t-the WHO, congenital abnormalities are major causes of fetal and infant mortality, chronic illness, and disabilities. Every year, an estimated 295 000 newborns nationwide die within 28 days of birth due t-congenital abnormalities. Thus, the rising prevalence of fetal abnormalities, increasing product launches, and established healthcare infrastructure propel the industry growth during the forecast period.
Based on the type, the expanded segment accounted for the leading share in the industry in 2021. Customized panel testing and predesigned panel testing are the extended segment components. Due t-advancements in DNA sequencing, polymerase chain reaction, metabolomics, and other technologies, the expanded sector accounted for most of the global market share in 2021.
Market players such as Abbott Laboratories, 23Andme Inc., Autogenomics Inc., Danaher Corporation, Fulgent Genetics Inc., Eurofins Scientific, Illumina Inc., Luminex Corporation, Invitae Corporation, MedGenome, Natera Inc., Myriad Genetics, Opk-Health, Quest Diagnostics Incorporated, Therm-Fisher Scientific Inc., Roche AG, Sequenom Inc., and True Health. are some key players operating in the global market.
Polaris Market Research has segmented the carrier screening market report based on type, medical condition, technology, end-user, and region:
Carrier Screening, Type Outlook (Revenue – USD Billion, 2018 – 2030)
The global carrier screening market size is expected t-reach USD 3.64 billion by 2030, according t-a new study by Polaris Market Research. The report “Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 – 2030” gives a detailed insight int-current market dynamics and provides analysis on future market growth.
The well-established healthcare infrastructure and the rise in innovative product introductions are driving the expansion of the industry. Many countries concentrate their efforts on developing enhanced medical infrastructure that includes enhanced treatment techniques.
Furthermore, developed-country nations have modern healthcare infrastructure integrated with various transmission methods, pushing the rise and need for these techniques throughout such countries. Many people wish t-discover if their genetic or inherited disorders might be transmitted t-their offerings. As a result, these factors are expected t-open up promising growth opportunities for companies in the overall industry during the forecasted period.
Additionally, the increasing prevalence of fetal chromosomal abnormalities boosts industry growth. According t-the WHO, congenital abnormalities are major causes of fetal and infant mortality, chronic illness, and disabilities. Every year, an estimated 295 000 newborns nationwide die within 28 days of birth due t-congenital abnormalities. Thus, the rising prevalence of fetal abnormalities, increasing product launches, and established healthcare infrastructure propel the industry growth during the forecast period.
Based on the type, the expanded segment accounted for the leading share in the industry in 2021. Customized panel testing and predesigned panel testing are the extended segment components. Due t-advancements in DNA sequencing, polymerase chain reaction, metabolomics, and other technologies, the expanded sector accounted for most of the global market share in 2021.
Market players such as Abbott Laboratories, 23Andme Inc., Autogenomics Inc., Danaher Corporation, Fulgent Genetics Inc., Eurofins Scientific, Illumina Inc., Luminex Corporation, Invitae Corporation, MedGenome, Natera Inc., Myriad Genetics, Opk-Health, Quest Diagnostics Incorporated, Therm-Fisher Scientific Inc., Roche AG, Sequenom Inc., and True Health. are some key players operating in the global market.
Polaris Market Research has segmented the carrier screening market report based on type, medical condition, technology, end-user, and region:
Carrier Screening, Type Outlook (Revenue – USD Billion, 2018 – 2030)
- Expanded
- Customized Panel Testing
- Predesigned Panel Testing
- Targeted Disease
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Other Conditions
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Other Technologies
- Hospitals
- Reference Laboratories
- Physician Offices & Clinics
- Other End Users
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Netherlands
- Spain
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
114 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Carrier Screening Market Insights
- 4.1. Carrier Screening – Industry Snapshot
- 4.2. Carrier Screening Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing emphasis on early disease detection & prevention
- 4.2.1.2. Increasing awareness of carrier screening
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of service
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Carrier Screening Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Carrier Screening Market, by Medical Condition
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 5.3. Pulmonary Conditions
- 5.3.1. Global Carrier Screening Market, by Pulmonary Conditions, by Region, 2018 - 2030 (USD Billion)
- 5.4. Hematological Conditions
- 5.4.1. Global Carrier Screening Market, by Hematological Conditions, by Region, 2018 - 2030 (USD Billion)
- 5.5. Neurological Conditions
- 5.5.1. Global Carrier Screening Market, by Neurological Conditions, by Region, 2018 - 2030 (USD Billion)
- 5.6. Other Conditions
- 5.6.1. Global Carrier Screening Market, by Other Conditions, by Region, 2018 - 2030 (USD Billion)
- 6. Global Carrier Screening Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 6.3. Expanded
- 6.3.1. Global Carrier Screening Market, by Expanded, by Region, 2018 - 2030 (USD Billion)
- 6.3.2. Customized Panel Testing
- 6.3.2.1. Global Carrier Screening Market, by Customized Panel Testing, by Region, 2018 - 2030 (USD Billion)
- 6.3.3. Predesigned Panel Testing
- 6.3.3.1. Global Carrier Screening Market, by Predesigned Panel Testing, by Region, 2018 - 2030 (USD Billion)
- 6.4. Targeted Disease
- 6.4.1. Global Carrier Screening Market, by Targeted Disease, by Region, 2018 - 2030 (USD Billion)
- 7. Global Carrier Screening Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 7.3. DNA Sequencing
- 7.3.1. Global Carrier Screening Market, by DNA Sequencing, by Region, 2018 - 2030 (USD Billion)
- 7.4. Polymerase Chain Reaction
- 7.4.1. Global Carrier Screening Market, by Polymerase Chain Reaction, by Region, 2018 - 2030 (USD Billion)
- 7.5. Microarrays
- 7.5.1. Global Carrier Screening Market, by Microarrays, by Region, 2018 - 2030 (USD Billion)
- 7.6. Other Technologies
- 7.6.1. Global Carrier Screening Market, by Other Technologies, by Region, 2018 - 2030 (USD Billion)
- 8. Global Carrier Screening Market, by End-User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global Carrier Screening Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
- 8.4. Reference Laboratories
- 8.4.1. Global Carrier Screening Market, by Reference Laboratories, by Region, 2018 - 2030 (USD Billion)
- 8.5. Physician Offices & Clinics
- 8.5.1. Global Carrier Screening Market, by Physician Offices & Clinics, by Region, 2018 - 2030 (USD Billion)
- 8.6. Other End Users
- 8.6.1. Global Carrier Screening Market, by Other End Users, by Region, 2018 - 2030 (USD Billion)
- 9. Global Carrier Screening Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 9.3. Carrier Screening Market – North America
- 9.3.1. North America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.5. Carrier Screening Market – U.S.
- 9.3.5.1. U.S.: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.3.5.2. U.S.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.5.3. U.S.: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.5.4. U.S.: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.6. Carrier Screening Market – Canada
- 9.3.6.1. Canada: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.3.6.2. Canada: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.6.3. Canada: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.6.4. Canada: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4. Carrier Screening Market – Europe
- 9.4.1. Europe: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.5. Carrier Screening Market – UK
- 9.4.5.1. UK: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.5.2. UK: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.5.3. UK: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.5.4. UK: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.6. Carrier Screening Market – France
- 9.4.6.1. France: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.6.2. France: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.6.3. France: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.6.4. France: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.7. Carrier Screening Market – Germany
- 9.4.7.1. Germany: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.7.2. Germany: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.7.3. Germany: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.7.4. Germany: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.8. Carrier Screening Market – Italy
- 9.4.8.1. Italy: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.8.2. Italy: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.8.3. Italy: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.8.4. Italy: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.9. Carrier Screening Market – Spain
- 9.4.9.1. Spain: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.9.2. Spain: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.9.3. Spain: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.9.4. Spain: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.10. Carrier Screening Market – Netherlands
- 9.4.10.1. Netherlands: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.10.2. Netherlands: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.10.3. Netherlands: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.10.4. Netherlands: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.11. Carrier Screening Market – Austria
- 9.4.11.1. Austria: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.11.2. Austria.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.11.3. Austria: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.11.4. Austria: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5. Carrier Screening Market – Asia Pacific
- 9.5.1. Asia Pacific: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.5. Carrier Screening Market – China
- 9.5.5.1. China: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.5.2. China.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.5.3. China: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.5.4. China: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.6. Carrier Screening Market – India
- 9.5.6.1. India: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.6.2. India.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.6.3. India: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.6.4. India: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.7. Carrier Screening Market – Japan
- 9.5.7.1. Japan: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.7.2. Japan.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.7.3. Japan: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.7.4. Japan: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.8. Carrier Screening Market – Malaysia
- 9.5.8.1. Malaysia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.8.2. Malaysia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.8.3. Malaysia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.8.4. Malaysia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.9. Carrier Screening Market – Indonesia
- 9.5.9.1. Indonesia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.9.2. Indonesia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.9.3. Indonesia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.9.4. Indonesia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.10. Carrier Screening Market – South Korea
- 9.5.10.1. South Korea: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.10.2. South Korea.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.10.3. South Korea: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.10.4. South Korea: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6. Carrier Screening Market – Middle East & Africa
- 9.6.1. Middle East & Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.5. Carrier Screening Market – Saudi Arabia
- 9.6.5.1. Saudi Arabia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.5.2. Saudi Arabia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.5.3. Saudi Arabia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.5.4. Saudi Arabia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.6. Carrier Screening Market – South Africa
- 9.6.6.1. South Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.6.2. South Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.6.3. South Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.6.4. South Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.7. Carrier Screening Market – Israel
- 9.6.7.1. Israel: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.7.2. Israel: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.7.3. Israel: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.7.4. Israel: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.8. Carrier Screening Market – UAE
- 9.6.8.1. UAE: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.8.2. UAE: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.8.3. UAE: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.8.4. UAE: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7. Carrier Screening Market – Latin America
- 9.7.1. Latin America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.5. Carrier Screening Market – Mexico
- 9.7.5.1. Mexico: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.5.2. Mexico: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.5.3. Mexico: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.5.4. Mexico: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.6. Carrier Screening Market – Brazil
- 9.7.6.1. Brazil: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.6.2. Brazil: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.6.3. Brazil: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.6.4. Brazil: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.7. Carrier Screening Market – Argentina
- 9.7.7.1. Argentina: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.7.2. Argentina: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.7.3. Argentina: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.7.4. Argentina: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. 23Andme Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Abbott Laboratories
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Autogenomics Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Danaher Corporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Eurofins Scientific
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Fulgent Genetics Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Illumina Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Invitae Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Luminex Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. MedGenome
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Myriad Genetics
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Natera Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Opko Health
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Quest Diagnostics Incorporated
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Roche AG
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Sequenom Inc.
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Thermo Fisher Scientific Inc.
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
- 11.18. True Health
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.